(PRESS RELEASE) STOCKHOLM, 30-Sep-2022 — /EuropaWire/ — Skanska (STO: SKA-B), a world leading project development and construction group, has announced that it has been contracted by RWJBarnabas, a network of independent healthcare providers, for the construction of a new ambulatory care cancer center in Livingston, NJ. United States. The construction project is worth nearly USD 60 million (about SEK 570 million) and will be included in the company’s US order bookings for the third quarter 2022.
The five-story building on the Cooperman Barnabas Medical Center campus, totaling 13,000 gross square meters, is designed to support patients’ care and wellbeing. The new facility will provide outpatient cancer treatment, including four new linear accelerators and a high-dose MRI unit. A parking garage will also be constructed.
Construction started September 2022, and completion is scheduled for July 2025.
For further information please contact:
Mia Walton, VP Communications, Skanska USA Building, tel + 1 (240) 672 17 89
Jacob Birkeland, Head of Media Relations and Public Affairs, Skanska AB, tel: +46 (0)10 449 19 57
Direct line for media, tel +46 (0)10 448 88 99
This and previous releases can also be found at www.skanska.com.
Skanska Group uses knowledge & foresight to shape the way people live, work, and connect. Over 135 years in the making, we’re one of the world’s largest project development and construction companies, with 2021 revenue totaling SEK 148 billion. We operate across select markets in the Nordics, Europe and USA. Together with our customers and the collective expertise of our 30,000 teammates, we create innovative and sustainable solutions that support healthy living beyond our lifetime
SOURCE: Skanska AB